Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Tobacco Induced Diseases
Metadata
Title
Economic evaluation of an exercise-counselling intervention to enhance smoking cessation outcomes: The Fit2Quit trial
Publication date
01-12-2017
Published in
Tobacco Induced Diseases / Issue 1/2017
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-017-0126-y

Other articles of this Issue 1/2017

Tobacco Induced Diseases 1/2017 Go to the issue

Research

Tumor necrosis factor-like weak inducer of apoptosis regulates quadriceps muscle atrophy and fiber-type alteration in a rat model of chronic obstructive pulmonary disease

Review

College anti-smoking policies and student smoking behavior: a review of the literature

Research

Changes in cigarette smoking initiation, cessation, and relapse among U.S. adults: a comparison of two longitudinal samples

Research

Physicians’ views on the role of smoking in smoking-related diseases: findings from cross-sectional studies from 1982–2014 in Estonia

Research

Correlates of e-cigarette ad awareness and likeability in U.S. young adults

Short report

Depression, anxiety and panic disorders in chronic obstructive pulmonary disease patients: correlations with tobacco use, disease severity and quality of life

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits